Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced expression of vasohibin-1 is associated with clinicopathological features in renal cell carcinoma
Guangning Zhao, Yuming Yang, Yang Tang, et al.
Medical Oncology (2012) Vol. 29, Iss. 5, pp. 3325-3334
Closed Access | Times Cited: 23

Showing 23 citing articles:

The vasohibin family: a novel family for angiogenesis regulation
Yasufumi Sato
The Journal of Biochemistry (2012) Vol. 153, Iss. 1, pp. 5-11
Open Access | Times Cited: 101
Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue
Koen M. Marien, Valerie Croons, Yannick Waumans, et al.
PLoS ONE (2016) Vol. 11, Iss. 9, pp. e0161496-e0161496
Open Access | Times Cited: 45
miR‐335‐5p induces insulin resistance and pancreatic islet β‐cell secretion in gestational diabetes mellitus mice through VASH1‐mediated TGF‐β signaling pathway
Xu‐Wen Tang, Qing-xin Qin
Journal of Cellular Physiology (2018) Vol. 234, Iss. 5, pp. 6654-6666
Closed Access | Times Cited: 36
Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma
Naoki Kanomata, Yasufumi Sato, Yoshiyuki Miyaji, et al.
Journal of Clinical Pathology (2013) Vol. 66, Iss. 7, pp. 613-619
Closed Access | Times Cited: 27
Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer
Tao Zhang, Tingting Yu, Dongming Zhang, et al.
Medical Oncology (2014) Vol. 31, Iss. 5
Closed Access | Times Cited: 25
Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
Soichi Ito, Hiroki Miyashita, Yasuhiro Suzuki, et al.
PLoS ONE (2013) Vol. 8, Iss. 9, pp. e73931-e73931
Open Access | Times Cited: 25
Vasohibin-1 suppresses colon cancer
Shuai Liu, Bing Han, Qunyuan Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 10, pp. 7880-7898
Open Access | Times Cited: 24
Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma
Shigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, et al.
HPB (2018) Vol. 20, Iss. 10, pp. 939-948
Open Access | Times Cited: 21
VASH-1 Regulates Oxidative Stress and Fibrosis in Diabetic Kidney Disease via SIRT1/HIF1α and TGFβ1/Smad3 Signaling Pathways
Huiwen Ren, Ying Shao, Can Wu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 20
Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients
Shuji Mikami, Mototsugu Oya, Takeo Kosaka, et al.
Laboratory Investigation (2017) Vol. 97, Iss. 7, pp. 854-862
Open Access | Times Cited: 19
Novel Link between Inhibition of Angiogenesis and Tolerance to Vascular Stress
Yasufumi Sato
Journal of Atherosclerosis and Thrombosis (2015) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 17
Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells
Megumu K. Saito, Yasuhiro Suzuki, Seiji Yano, et al.
The Journal of Biochemistry (2016) Vol. 160, Iss. 4, pp. 227-232
Open Access | Times Cited: 15
Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma
Chisaho Torii, Yasuhiro Hida, Masanobu Shindoh, et al.
Anticancer Research (2017) Vol. 37, Iss. 3, pp. 1219-1226
Open Access | Times Cited: 16
High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
Tatsuaki Watanabe, Tomoko Hosaka, Kaori Ohmori‐Matsuda, et al.
Health Science Reports (2018) Vol. 1, Iss. 6
Open Access | Times Cited: 12
The expression of vasohibin-1 and its prognostic significance in bladder cancer
Bo Zhang, Zhouliang Wu, Wanqin Xie, et al.
Experimental and Therapeutic Medicine (2017) Vol. 14, Iss. 4, pp. 3477-3484
Open Access | Times Cited: 11
Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma
Guangning Zhao, Na Ren, Liming Li, et al.
Oncology Reports (2017) Vol. 38, Iss. 2, pp. 1021-1028
Open Access | Times Cited: 9
Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer
Mingliang Feng, Ming-Jun Sun, Boyang Xu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 24, pp. 3770-3792
Open Access | Times Cited: 3
Renal distribution of Vasohibin-1 in patients with chronic kidney disease.
Norikazu Hinamoto, Yohei Maeshima, Daisuke Saito, et al.
PubMed (2014) Vol. 68, Iss. 4, pp. 219-33
Closed Access | Times Cited: 7
Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration
Deliang Ma, Jingye Li, Jinbao Wang, et al.
Molecular Medicine Reports (2017) Vol. 16, Iss. 2, pp. 1479-1485
Open Access | Times Cited: 6
Vasohibin 1 inhibits Adriamycin resistance in osteosarcoma cells via the protein kinase B signaling pathway
Wei Huang, Yangguang Ren, Hui Liu
Oncology Letters (2018)
Open Access | Times Cited: 5
circASS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells by regulating the miR‑1269a/VASH1 axis
Hailin Xiong, Xiaohua Zhong, Xiaohong Guo, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 4
Open Access | Times Cited: 5
Determining the Vasohibin-1 Levels of the Serum and Broncoalveolar Lavage Fluid in the Patients with Lung Cancer”
Alev Lazoğlu Özkaya, Mevlüt Sait Keleş, Esra Laloğlu, et al.
Konuralp Tıp Dergisi (2022) Vol. 14, Iss. 2, pp. 298-303
Open Access
Page 1

Scroll to top